End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.77 MXN | -4.51% | +6.53% | +25.49% |
Business Summary
Number of employees: 1,590
Sales per Business
MXN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Personal Care Products
100.0
%
| 16,820 | 100.0 % | 16,467 | 100.0 % | -2.10% |
Sales per region
MXN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
51.2
%
| 10,069 | 59.9 % | 8,431 | 51.2 % | -16.27% |
Mexico
48.8
%
| 6,751 | 40.1 % | 8,037 | 48.8 % | +19.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - | |
Director/Board Member | - | 18-09-09 | |
Director/Board Member | - | 12-03-28 | |
Public Communications Contact | - | 08-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Director/Board Member | - | - | |
Founder | - | 96-10-29 | |
Director/Board Member | - | 97-12-31 | |
Director/Board Member | 80 | - | |
Director/Board Member | - | 12-03-28 | |
Director/Board Member | - | 18-09-09 | |
Director/Board Member | - | 18-04-17 | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,020,000,000 | 712,097,600 ( 69.81 %) | 74,855,920 ( 7.339 %) | 69.81 % |
Company contact information
Genomma Lab Internacional SAB de CV
Avendia Antonio Dovalí Jaime, 70 Torre C, Piso 2, Despacho A
01210, Mexico City
+
http://www.genommalab.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.49% | 986M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- LAB B Stock
- Company Genomma Lab Internacional, S.A.B. de C.V.